243 related articles for article (PubMed ID: 21147885)
1. Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location.
Eisenhofer G; Timmers HJ; Lenders JW; Bornstein SR; Tiebel O; Mannelli M; King KS; Vocke CD; Linehan WM; Bratslavsky G; Pacak K
J Clin Endocrinol Metab; 2011 Feb; 96(2):375-84. PubMed ID: 21147885
[TBL] [Abstract][Full Text] [Related]
2. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.
Eisenhofer G; Walther MM; Huynh TT; Li ST; Bornstein SR; Vortmeyer A; Mannelli M; Goldstein DS; Linehan WM; Lenders JW; Pacak K
J Clin Endocrinol Metab; 2001 May; 86(5):1999-2008. PubMed ID: 11344198
[TBL] [Abstract][Full Text] [Related]
3. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
Eisenhofer G; Lenders JW; Linehan WM; Walther MM; Goldstein DS; Keiser HR
N Engl J Med; 1999 Jun; 340(24):1872-9. PubMed ID: 10369850
[TBL] [Abstract][Full Text] [Related]
4. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
5. Phaeochromocytoma: a catecholamine and oxidative stress disorder.
Pacak K
Endocr Regul; 2011 Apr; 45(2):65-90. PubMed ID: 21615192
[TBL] [Abstract][Full Text] [Related]
6. Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution.
Eisenhofer G; Vocke CD; Elkahloun A; Huynh TT; Prodanov T; Lenders JW; Timmers HJ; Benhammou JN; Linehan WM; Pacak K
Horm Metab Res; 2012 May; 44(5):343-8. PubMed ID: 22438210
[TBL] [Abstract][Full Text] [Related]
7. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.
Eisenhofer G; Pacak K; Huynh TT; Qin N; Bratslavsky G; Linehan WM; Mannelli M; Friberg P; Grebe SK; Timmers HJ; Bornstein SR; Lenders JW
Endocr Relat Cancer; 2011 Feb; 18(1):97-111. PubMed ID: 21051559
[TBL] [Abstract][Full Text] [Related]
8. Pheochromocytoma: the expanding genetic differential diagnosis.
Bryant J; Farmer J; Kessler LJ; Townsend RR; Nathanson KL
J Natl Cancer Inst; 2003 Aug; 95(16):1196-204. PubMed ID: 12928344
[TBL] [Abstract][Full Text] [Related]
9. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.
Eisenhofer G; Lenders JW; Timmers H; Mannelli M; Grebe SK; Hofbauer LC; Bornstein SR; Tiebel O; Adams K; Bratslavsky G; Linehan WM; Pacak K
Clin Chem; 2011 Mar; 57(3):411-20. PubMed ID: 21262951
[TBL] [Abstract][Full Text] [Related]
10. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome.
Eisenhofer G; Huynh TT; Pacak K; Brouwers FM; Walther MM; Linehan WM; Munson PJ; Mannelli M; Goldstein DS; Elkahloun AG
Endocr Relat Cancer; 2004 Dec; 11(4):897-911. PubMed ID: 15613462
[TBL] [Abstract][Full Text] [Related]
11. Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B.
Brouwers FM; Gläsker S; Nave AF; Vortmeyer AO; Lubensky I; Huang S; Abu-Asab MS; Eisenhofer G; Weil RJ; Park DM; Linehan WM; Pacak K; Zhuang Z
Endocr Relat Cancer; 2007 Jun; 14(2):463-71. PubMed ID: 17639059
[TBL] [Abstract][Full Text] [Related]
12. Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma.
Jiang J; Zhang J; Pang Y; Bechmann N; Li M; Monteagudo M; Calsina B; Gimenez-Roqueplo AP; Nölting S; Beuschlein F; Fassnacht M; Deutschbein T; Timmers HJLM; Åkerström T; Crona J; Quinkler M; Fliedner SMJ; Liu Y; Guo J; Li X; Guo W; Hou Y; Wang C; Zhang L; Xiao Q; Liu L; Gao X; Burnichon N; Robledo M; Eisenhofer G
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32750708
[TBL] [Abstract][Full Text] [Related]
13. Familial pheochromocytoma.
Erlic Z; Neumann HP
Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
[TBL] [Abstract][Full Text] [Related]
14. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
Eisenhofer G; Deutschbein T; Constantinescu G; Langton K; Pamporaki C; Calsina B; Monteagudo M; Peitzsch M; Fliedner S; Timmers HJLM; Bechmann N; Fankhauser M; Nölting S; Beuschlein F; Stell A; Fassnacht M; Prejbisz A; Lenders JWM; Robledo M
Clin Chem Lab Med; 2020 Oct; 59(2):353-363. PubMed ID: 33001846
[TBL] [Abstract][Full Text] [Related]
15. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
[TBL] [Abstract][Full Text] [Related]
16. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
Butz JJ; Yan Q; McKenzie TJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
Surgery; 2017 Dec; 162(6):1259-1269. PubMed ID: 28919049
[TBL] [Abstract][Full Text] [Related]
17. Adrenal cortical tumors, pheochromocytomas and paragangliomas.
Lloyd RV
Mod Pathol; 2011 Apr; 24 Suppl 2():S58-65. PubMed ID: 21455202
[TBL] [Abstract][Full Text] [Related]
18. Lack of utility of SDHB mutation testing in adrenergic metastatic phaeochromocytoma.
Sue M; Martucci V; Frey F; Lenders JM; Timmers HJ; Peczkowska M; Prejbisz A; Swantje B; Bornstein SR; Arlt W; Fassnacht M; Beuschlein F; Robledo M; Pacak K; Eisenhofer G
Eur J Endocrinol; 2015 Feb; 172(2):89-95. PubMed ID: 25371406
[TBL] [Abstract][Full Text] [Related]
19. How to detect pheochromocytomas?--the diagnostic relevance of plasma free metanephrines.
Roden M
Wien Klin Wochenschr; 2002 Apr; 114(7):246-51. PubMed ID: 12089859
[TBL] [Abstract][Full Text] [Related]
20. Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice.
Zelinka T; Eisenhofer G; Pacak K
Stress; 2007 Jun; 10(2):195-203. PubMed ID: 17514588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
